Balter Invenomic Fund Manager Performance Evaluation
| BIVIX Fund | USD 17.58 0.26 1.50% |
The fund shows a Beta (market volatility) of -0.1, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Balter Invenomic are expected to decrease at a much lower rate. During the bear market, Balter Invenomic is likely to outperform the market.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Balter Invenomic Fund has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong forward indicators, Balter Invenomic is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
...more| Expense Ratio Date | 1st of March 2023 | |
| Expense Ratio | 3.0800 |
Balter |
Balter Invenomic Relative Risk vs. Return Landscape
If you would invest 1,806 in Balter Invenomic Fund on August 31, 2024 and sell it today you would lose (48.00) from holding Balter Invenomic Fund or give up 2.66% of portfolio value over 90 days. Balter Invenomic Fund is currently producing negative expected returns and takes up 0.6396% volatility of returns over 90 trading days. Put another way, 5% of traded mutual funds are less volatile than Balter, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Balter Invenomic Current Valuation
Overvalued
Today
Please note that Balter Invenomic's price fluctuation is very steady at this time. At this time, the entity appears to be overvalued. Balter Invenomic shows a prevailing Real Value of $16.34 per share. The current price of the fund is $17.58. We determine the value of Balter Invenomic from analyzing fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we favor acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will blend.
Since Balter Invenomic is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Balter Mutual Fund. However, Balter Invenomic's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 17.58 | Real 16.34 | Hype 17.58 |
The intrinsic value of Balter Invenomic's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Balter Invenomic's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Balter Invenomic Fund helps investors to forecast how Balter mutual fund's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Balter Invenomic more accurately as focusing exclusively on Balter Invenomic's fundamentals will not take into account other important factors: Balter Invenomic Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Balter Invenomic's investment risk. Standard deviation is the most common way to measure market volatility of mutual funds, such as Balter Invenomic Fund, and traders can use it to determine the average amount a Balter Invenomic's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0637
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | BIVIX |
Estimated Market Risk
| 0.64 actual daily | 5 95% of assets are more volatile |
Expected Return
| -0.04 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Balter Invenomic is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Balter Invenomic by adding Balter Invenomic to a well-diversified portfolio.
Balter Invenomic Fundamentals Growth
Balter Mutual Fund prices reflect investors' perceptions of the future prospects and financial health of Balter Invenomic, and Balter Invenomic fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Balter Mutual Fund performance.
| Total Asset | 901.55 M | |||
About Balter Invenomic Performance
Evaluating Balter Invenomic's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Balter Invenomic has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Balter Invenomic has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
The fund invests primarily in both long and short positions in equity securities principally traded in United States markets. Under normal market conditions, the Sub-Adviser seeks to be fully invested in the long portfolio , while allowing the size of the short portfolio to fluctuate based on the market opportunity. The fund may invest in equity securities of any type and across all market capitalizations. It may invest in securities of companies operating less than three years and in initial public offerings of securities .Things to note about Balter Invenomic performance evaluation
Checking the ongoing alerts about Balter Invenomic for important developments is a great way to find new opportunities for your next move. Mutual Fund alerts and notifications screener for Balter Invenomic help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Balter Invenomic generated a negative expected return over the last 90 days | |
| The fund holds about 70.47% of its assets under management (AUM) in cash |
- Analyzing Balter Invenomic's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Balter Invenomic's stock is overvalued or undervalued compared to its peers.
- Examining Balter Invenomic's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Balter Invenomic's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Balter Invenomic's management team can help you assess the Mutual Fund's leadership.
- Pay attention to analyst opinions and ratings of Balter Invenomic's mutual fund. These opinions can provide insight into Balter Invenomic's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Balter Mutual Fund
Balter Invenomic financial ratios help investors to determine whether Balter Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Balter with respect to the benefits of owning Balter Invenomic security.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |